Bruker Corporation (NASDAQ:BRKR) is set to announce third quarter earning results on Monday 2nd November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, BRKR to report 3Q20 income of $ 0.31 per share.
For the full year, analysts anticipate top line of $ 1921.91 million, while looking forward to income of $ 1.21 per share bottom line.
Previous Quarter Performance
Bruker Corporation disclosed income for the second quarter of $ 0.21 per share, from the revenue of $ 424.60 million. The quarterly earnings 36.36 percent while revenues contracted 11.13 percent compared with the same quarter last year.
Wall street analysts are predicting, BRKR to report 2Q20 income of $ 0.06 per share from revenue of $ 390.92 million. The bottom line results beat street analysts by $ 0.15 or 250.00 percent, at the same time, top line results outshined analysts by $ 33.68 million or 8.62 percent.
Stock Performance
On Friday, shares of Bruker Corporation has traded high as $ 42.67 and has cracked $ 41.31 on the downward trend, reaching $ 42.54 with volume of 463.40 thousand shares.
According to the previous trading day, closing price of $ 42.54, representing a 36.42 % increase from the 52 week low of $ 30.78 and a 22.94 % decrease over the 52 week high of $ 54.49.
The company has a market capital of $ 6.51 billion and is part of the Healthcare sector and Diagnostics & Research industry.
Recent Stock Dividend Announcement
On August 7, 2020, the board of directors authorized quarterly dividend of $ 0.04 per share to holders of record as of the close of business on September 1, 2020, with payment date of September 18, 2020 and ex-dividend date on August 31, 2020.
Conference Call
Bruker Corporation will be hosting a conference call at 4:30 PM eastern time on 2nd November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.bruker.com
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
